J 2017

The Role of High-Field Magnetic Resonance Imaging in Parkinsonian Disorders: Pushing the Boundaries Forward

LEHERICY, S., D.E. VAILLANCOURT, K. SEPPI, O. MONCHI, Irena REKTOROVÁ et. al.

Basic information

Original name

The Role of High-Field Magnetic Resonance Imaging in Parkinsonian Disorders: Pushing the Boundaries Forward

Authors

LEHERICY, S. (250 France), D.E. VAILLANCOURT (840 United States of America), K. SEPPI (40 Austria), O. MONCHI (124 Canada), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), A. ANTONINI (380 Italy), M.J. MCKEOWN (124 Canada), M. MASELLIS (124 Canada), D. BERG (276 Germany), J.B. ROWE (826 United Kingdom of Great Britain and Northern Ireland), S.J.G. LEWIS (36 Australia), C.H. WILLIAMS-GRAY (826 United Kingdom of Great Britain and Northern Ireland), A. TESSITORE (380 Italy) and H.R. SIEBNER (208 Denmark)

Edition

Movement Disorders, HOBOKEN, WILEY, 2017, 0885-3185

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30103 Neurosciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 8.324

RIV identification code

RIV/00216224:14110/17:00099905

Organization unit

Faculty of Medicine

UT WoS

000399758800005

Keywords in English

Parkinson's disease; atypical parkinsonism; MRI; iron; neuromelanin; diffusion MRI; fMRI; resting state fMRI; 7T

Tags

Tags

International impact, Reviewed
Změněno: 21/3/2018 16:30, Soňa Böhmová

Abstract

V originále

Historically, magnetic resonance imaging (MRI) has contributed little to the study of Parkinson's disease (PD), but modern MRI approaches have unveiled several complementary markers that are useful for research and clinical applications. Iron- and neuromelanin-sensitive MRI detect qualitative changes in the substantia nigra. Quantitative MRI markers can be derived from diffusion weighted and iron-sensitive imaging or volumetry. Functional brain alterations at rest or during task performance have been captured with functional and arterial spin labeling perfusion MRI. These markers are useful for the diagnosis of PD and atypical parkinsonism, to track disease progression from the premotor stages of these diseases and to better understand the neurobiological basis of clinical deficits. A current research goal using MRI is to generate time-dependent models of the evolution of PD biomarkers that can help understand neurodegeneration and provide reliable markers for therapeutic trials. This article reviews recent advances in MRI biomarker research at high-field (3T) and ultra high field-imaging (7T) in PD and atypical parkinsonism. (c) 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.